FDA: Coronavirus (COVID-19) Update: FDA updates on surveillance inspections during COVID-19
During COVID-19, the U.S. Food and Drug Administration will continue to utilize and implement additional alternative inspection tools and approaches while postponing domestic and foreign routine surveillance inspections.